Bovine serum albumin/gold nanoparticles as a drug delivery system for Curcumin: experimental and computational studies

Bahareh Khodashenas,Mehdi Ardjmand,Mazyar Sharifzadeh Baei,Ali Shokuhi Rad,Azim Akbarzadeh Khiyavi

DOI: https://doi.org/10.1080/07391102.2019.1683073

2019-10-30

Journal of Biomolecular Structure and Dynamics

Abstract:Communicated by Ramaswamy H. Sarma.

What problem does this paper attempt to address?

Preparation and Characterization of Bovine Serum Albumin Nanoparticles of Curcumin using a Chemometric Approach

Ayesha Syed,Preeti Karwa,V. Kusum Devi

DOI: https://doi.org/10.18311/jnr/2022/30392

2022-12-16

Journal of Natural Remedies

Abstract:Bovine Serum Albumin (BSA) has been presupposed to be a versatile protein polymer for targeted drug delivery. BSA nanoparticles can lead to passive targeting of drugs to the inflamed joint via the Enhanced Permeability and Retention (EPR) effect and due to their specific affinity towards the inflamed joint because of the inadequacy of protein in the affected region. Hence, the aim of the study was to develop BSA nanoparticles loading curcumin (BSA_CUR_NPs) by nanoparticle albuminbound technology and its optimization was conducted by 33 Box Behnken Design (BBD) in order to achieve the desired particle size and entrapment efficiency. Further, the optimised nanoparticles were also assessed for polydispersity index, zeta potential, total drug content, and in-vitro drug release study. The response surface plots and equations generated by BBD predicted the relationship between variables under study. The optimised formulation C12 was found to have a particle size of 207.1 ± 1.36nm, PDI of 0.138 ± 0.03, entrapment efficiency of 75.04 ± 0.06 %, total drug content of 91.40 ± 0.08% and zeta potential of -32.9mV. The optimised nanoparticles exhibited good sustained release for up to 8 days. The use of a chemometric approach led to the development of BSA_CUR_NPs with the desired characteristics with a less experimental procedure. Therefore, it presents an important model for producing the nanoparticles of the desired characteristics using albumin as a polymer for the enhanced and sustained delivery of loaded drugs to the inflamed joint.
Bovine Serum Albumin-Based Nanoparticles: Preparation, Characterization, and Antioxidant Activity Enhancement of Three Main Curcuminoids from Curcuma longa

Andrea Mariela Araya-Sibaja,Krissia Wilhelm-Romero,María Isabel Quirós-Fallas,Luis Felipe Vargas Huertas,José Roberto Vega-Baudrit,Mirtha Navarro-Hoyos

DOI: https://doi.org/10.3390/molecules27092758

IF: 4.6

2022-04-25

Molecules

Abstract:Bovine Serum Albumin (BSA) lipid hybrid nanoparticles are part of the new solutions to overcome low bioavailability of poor solubility drugs such as curcuminoids, which possess multiple biological advantages; however, they are counterbalanced by its short biological half-life. In this line, we prepared the three main curcuminoids: curcumin (CUR), desmethoxycurcumin (DMC), and bisdemethoxycurcumin (BDM)-loaded BSA nanoparticles. The three formulations were characterized by the average size, size distribution, crystallinity, weight loss, drug release, kinetic mechanism, and antioxidant activity. The developed method produced CUR-, DMC-, and BDM-loaded BSA nanoparticles with a size average of 15.83 ± 0.18, 17.29 ± 3.34, and 15.14 ± 0.14 nm for CUR, DMC, and BDM loaded BSA, respectively. FT-IR analysis confirmed the encapsulation, and TEM images showed their spherical shape. The three formulations achieved encapsulation efficiency upper to 96% and an exhibited significantly increased release from the nanoparticle compared to free compounds in water. The antioxidant activity was enhanced as well, in agreement with the improvement in water release, obtaining IC50 values of 9.28, 11.70, and 15.19 μg/mL for CUR, DMC, and BDM loaded BSA nanoparticles, respectively, while free curcuminoids exhibited considerably lower antioxidant values in aqueous solution. Hence, this study shows promises for such hybrid systems, which have been ignored so far, regarding proper encapsulation, protection, and delivery of curcuminoids for the development of functional foods and pharmaceuticals.

chemistry, multidisciplinary,biochemistry & molecular biology
Preparation and Characterization of PEG-albumin-curcumin Nanoparticles Intended to Treat Breast Cancer

R Thadakapally,Arshiya Aafreen,J Aukunuru,M Habibuddin,S Jogala

DOI: https://doi.org/10.4103/0250-474x.180250

Abstract:The aim of present research was to prepare novel serum stable long circulating polymeric nanoparticles for curcumin with a modification to the well known and novel nanoparticle albumin bound technology. polyethylene glycol-albumin-curcumin nanoparticles were prepared using serum albumin and poly ethylene glycol using desolvation technique. Nanoparticles were characterized for encapsulation efficiency, particle size and surface morphology. Drug excipient compatibility was determined using fourier transform infrared spectroscopy. Physical state of the drug in the formulations was known by differential scanning colorimetry. In vitro release and solubility of the drug from nanoparticles were determined. In vivo Drug release, tissue uptake and kupffer cell uptake was determined with optimized nanoformulation in rats after intravenous administration. Cell viability assay was determined using breast cancer cell line MD-MB-231. Entrapment efficiency for prepared nanoparticle was above 95%. The polyethylene glycol-albumin-curcumin nanoparticles exhibited an interesting release profile with small initial burst followed by slower and controlled release. Solubility of the drug from the formulation was increased. A sustained release of drug from nanoparticles was observed for 35 days in both in vitro and in vivo studies with the optimized formulation. Polyethylene glycol-albumin-curcumin nanoparticles showed lesser liver and kupffer cell uptake as compared to that of curcumin-albumin nanoparticles suggesting the bestowment of stealthness to nanoparticles with pegylation. Also, the antiproliferative activity of polyethylene glycol-albumin-curcumin nanoparticle formulation was more as compared to native curcumin. Polyethylene glycol-albumin-curcumin nanoparticles thus developed can be conveniently used in breast cancer with improved efficacy compared to conventional therapies and as an alternate to nanoparticle albumin bound technology which is used in producing Abraxane, albumin based breast cancer targeting nanoparticles of paclitaxel.
Fabrication of Ovalbumin/κ-Carrageenan Complex Nanoparticles As a Novel Carrier for Curcumin Delivery

Hujun Xie,Chuyue Xiang,Yang Li,Lihong Wang,Yutong Zhang,Zhijun Song,Xiangjuan Ma,Xiaoxing Lu,Qunfang Lei,Wenjun Fang

DOI: https://doi.org/10.1016/j.foodhyd.2018.10.027

IF: 10.7

2018-01-01

Food Hydrocolloids

Abstract:Natural biopolymers are biocompatible and biodegradable, and have been a focus on the research of biologically active carrier materials. In this manuscript, the nanoparticles of ovalbumin/kappa-carrageenan (OVA-CRG) complex were fabricated to encapsulate and protect curcumin under moderate conditions, forming the ovalbuminbccarrageenan/curcumin (OVA-CRG-CUR) complex nanoparticles. The OVA-CRG complex nanoparticles show good curcumin entrapping performance, and the addition of curcumin does not affect the emulsifying stability (ES) and emulsifying activity (EA) of OVA-CRG complex nanoparticles. The maximum ES of OVA-CRG-CUR is reached at 36 h with the value of 84.6 min, and the maximum EA is reached at 48 h with the value of 74.2 m(2)/g. The encapsulated curcumin demonstrates high antioxidation activity, while its thermal and light stabilities of curcumin are both increased. The release behavior of curcumin is further studied in simulated gastric and intestinal fluids. The lower release rate of curcumin in simulated gastric fluid with the final value of 12.9% after 3 h indicates that the OVA-CRG complex nanoparticles are good carriers for improving the stability of curcumin in acidic environment, and are able to enhance the bioavailability of curcumin by a gradual release in intestine. Present researches elucidate that proteins-polysaccharides complex nanoparticles are feasible to solubilize and protect sensitive amphiphilic bioactive compounds and have extensive potential in food and medicinal applications.
Nanoparticulation of bovine serum albumin and poly-d-lysine through complex coacervation and encapsulation of curcumin

L Maldonado,R Sadeghi,J Kokini

DOI: https://doi.org/10.1016/j.colsurfb.2017.08.047

2017-11-01

Abstract:Soluble coacervate nanoparticles were fabricated by mixing bovine serum albumin (BSA) and poly-d-lysine with low (LMW-PDL) and high molecular weights (HMW-PDL). The particle size was influenced by molecular weight, mass ratio of polyelectrolytes (PEs), and salt concentration. The smallest nanoparticles had a diameter of 212±11nm which was achieved with LMW-PDL dissolved with 0.1M NaCl at pH 7 and a mass ratio of 2.0 (BSA: PDL). SEM images showed that coacervate nanoparticles of LMW-PDL are relatively spherical in shape, while nanoparticles of HMW-PDL were irregular. Crosslinking of the protein/polypeptide with glutaraldehyde had variable impact on the stability and particle size over 21days at 4 and 25°C. The encapsulation efficiency (EE) for curcumin to BSA molar ratio of 0.5 was 47%. The EE increased to 60% when the curcumin to BSA molar ratio was 10 with a loading capacity of 22μg of curcumin per mg of coacervate nanoparticles. The average particle size of the loaded colloidal dispersions increased as the curcumin concentration was increased. For the colloidal dispersions with 0.5 molar ratio of curcumin to BSA, the particle size was around 204±14nm at day 1, while the nanoparticles with molar ratio of 10 showed a particle size around 316±43nm. The curcumin loaded BSA:LMW-PDL nanoparticles were pretty stable over a period of 21days.
Interactions of Turmeric- and Curcumin-Functionalized Gold Nanoparticles with Human Serum Albumin: Exploration of Protein Corona Formation, Binding, Thermodynamics, and Antifibrillation Studies

Kakali Baruah,Ajit Kumar Singh,Kalpana Kumari,Dasuk Lyngdoh Nongbri,Anupam Nath Jha,Atanu Singha Roy

DOI: https://doi.org/10.1021/acs.langmuir.3c03032

IF: 3.9

2024-01-16

Langmuir

Abstract:In order to better understand the bioavailability and biocompatibility of polyphenol-assisted surface-modified bioengineered nanoparticles in nanomedicine applications, here, we address a series of photophysical experiments to quantify the binding affinity of serum albumin toward polyphenol-capped gold nanoparticles. For this, two different gold nanoparticles (AuNPs) were synthesized via the green synthesis approach, where curcumin and turmeric extract act as reducing as well as capping agents. The size, surface charge, and surface plasmon bands of the AuNPs were highly affected by the adsorption of human serum albumin (HSA) during protein corona formation, which was investigated using dynamic light scattering (DLS), ξ-potential, ultraviolet-visible (UV-vis) spectroscopy, and transmission electron microscopy (TEM) measurements. Fluorescence-based methods, absorbance, and SERS experiments were carried out to evaluate the binding aspects of AuNPs with HSA. We found that the AuNPs show moderate binding affinity toward HSA (Kb ∼ 104 M-1), irrespective of the capping agents on the surface. Hydrophobic association, along with some contribution of electrostatic interaction, played a key role in the binding process. The binding interaction was more toward the subdomain IIA region of HSA, as indicated by the competitive displacement studies using site-specific binders (warfarin and flufenamic acid). Because of the large surface curvature of small-sized AuNPs, the secondary structural conformations of HSA were slightly altered, as revealed by circular dichroism (CD), Fourier transform infrared (FT-IR) spectroscopy, and surface-enhanced Raman scattering (SERS) measurements. Additionally, the findings of the binding interactions were re-evaluated using molecular dynamics (MD) simulation studies by determining the root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg), and changes in the binding energy of HSA upon complexation with AuNPs. To determine the tentative evidence for pharmacokinetic administration, these biocompatible AuNPs were applied to inhibit the amyloid fibril formation of HSA and monitored by using the thioflavin T (ThT) assay, ANS fluorescence assay, fluorescence microscopic imaging, and FESEM. AuNPs were found to show better resistance toward fibrillation of the adsorbed protein.
In Vitro Characterization and in Vivo Evaluation of Nanostructured Lipid Curcumin Carriers for Intragastric Administration

Min Fang,Yilin Jin,Wei Bao,Hui Gao,Mengjin Xu,Di Wang,Xia Wang,Ping Yao,Liegang Liu

DOI: https://doi.org/10.2147/ijn.s36257

IF: 7.033

2012-01-01

International Journal of Nanomedicine

Abstract:Background: Curcumin has a variety of pharmacological effects. However, poor water solubility and low oral bioavailability limit its clinical utility. A delivery system for nanostructured lipid carriers has been reported to be a promising approach to enhancing the oral absorption of curcumin. The aim of the present study was to investigate the pharmacokinetics, tissue distribution, and relative bioavailability of curcumin in rats after a single intragastric dose of a nanostructured lipid curcumin carrier formulation.Methods: Nanostructured lipid curcumin carriers were prepared using the ethanol dripping method and characterized in terms of the particle size, polydispersity index, zeta potential, differential scanning calorimetry, drug-loading capacity, encapsulation efficiency, and in vitro release. The pharmacokinetics and tissue distribution of nanostructured lipid curcumin carriers and curcumin suspension were compared after intragastric administration.Results: Nanostructured lipid curcumin carriers showed a significantly higher peak plasma concentration (564.94 +/- 14.98 ng/mL versus 279.43 +/- 7.21 ng/mL, P<0.01), a shorter time taken to reach peak plasma concentration (0.5 +/- 0.01 hour versus 1.0 +/- 0.12 hour, P. 0.01), and a greater AUC(0-infinity) (820.36 +/- 25.11 mg x hour/L versus 344.11 +/- 10.01 mg x hour/L, P < 0.05) compared with curcumin suspension. In the tissue distribution studies, curcumin could be detected in the spleen, heart, liver, kidneys, lungs, and brain. Following intragastric administration of the nanostructured lipid curcumin carrier formulation, tissue concentrations of curcumin also increased, especially in the brain. The nanostructured lipid curcumin carrier formulation improved the ability of curcumin to cross the blood-brain barrier, with an 11.93-fold increase in the area under the curve achieved in the brain when compared with curcumin suspension.Conclusion: The nanostructured lipid carrier formulation significantly improved the oral bioavailability of curcumin and represents a promising method for its oral delivery.
Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations

Jibira Yakubu,Amit V. Pandey

DOI: https://doi.org/10.3390/pharmaceutics16050637

IF: 6.525

2024-05-10

Pharmaceutics

Abstract:Curcumin, a polyphenol with a rich history spanning two centuries, has emerged as a promising therapeutic agent targeting multiple signaling pathways and exhibiting cellular-level activities that contribute to its diverse health benefits. Extensive preclinical and clinical studies have demonstrated its ability to enhance the therapeutic potential of various bioactive compounds. While its reported therapeutic advantages are manifold, predominantly attributed to its antioxidant and anti-inflammatory properties, its efficacy is hindered by poor bioavailability stemming from inadequate absorption, rapid metabolism, and elimination. To address this challenge, nanodelivery systems have emerged as a promising approach, offering enhanced solubility, biocompatibility, and therapeutic effects for curcumin. We have analyzed the knowledge on curcumin nanoencapsulation and its synergistic effects with other compounds, extracted from electronic databases. We discuss the pharmacokinetic profile of curcumin, current advancements in nanoencapsulation techniques, and the combined effects of curcumin with other agents across various disorders. By unifying existing knowledge, this analysis intends to provide insights into the potential of nanoencapsulation technologies to overcome constraints associated with curcumin treatments, emphasizing the importance of combinatorial approaches in improving therapeutic efficacy. Finally, this compilation of study data aims to inform and inspire future research into encapsulating drugs with poor pharmacokinetic characteristics and investigating innovative drug combinations to improve bioavailability and therapeutic outcomes.

pharmacology & pharmacy
Berberine-Loaded Bovine Serum Albumin Nanoparticles: Fabrication, Characterization, and Drug Release Evaluation

M Abdelmonem,A Hemdan,D Ghareeb,M El demellawy,M Abdelmageed,H Wasim,M El sayed

DOI: https://doi.org/10.1093/ajcp/aqae129.050

2024-10-01

American Journal of Clinical Pathology

Abstract:Abstract Introduction/Objective Introduction: Numerous studies have highlighted the diverse biochemical and pharmacological properties of berberine (BER), including its anti-inflammatory, antioxidant, anticancer, and hypolipidemic effects. Nanoparticles play a crucial role in enhancing drug delivery by providing a larger surface area, facilitating quicker dissolution in the bloodstream. Methods/Case Report Methods: Blank bovine serum albumin nanoparticles (BSA NPs) were prepared using a desolvation process, followed by the fabrication of berberine-loaded BSA nanoparticles (BER-NP). Physicochemical characterization, including particle size and zeta potential, was conducted using a Malvern Zetasizer. The mean particle size and distribution were determined using photon correlation spectroscopy (PCS), and transmission electron microscope (TEM) images were obtained for visualization. Fourier transform infrared (FTIR) spectra and differential scanning calorimetry (DSC) thermograms were recorded to assess drug encapsulation efficiency (EE). Berberine release from BER-NPs was evaluated using dialysis membranes. Results (if a Case Study enter NA) Results: FTIR spectra and DSC thermograms confirmed successful drug loading into the nanoparticles. Encapsulation efficiency was determined by UV absorption spectroscopy, revealing high efficiency in the encapsulation process. Dialysis membranes demonstrated controlled release kinetics of berberine from BER-NPs, indicating their potential for targeted drug delivery. Conclusion Conclusion: Berberine-loaded bovine serum albumin nanoparticles exhibit favorable characteristics for drug delivery applications, including enhanced permeation across biological barriers. These nanoparticles hold promise for targeted therapy and combination drug regimens, offering potential benefits for various medical interventions.

pathology
Novel Curcumin-Loaded Human Serum Albumin Nanoparticles Surface Functionalized with Folate: Characterization and in Vitro/vivo Evaluation

Zhiwang Song,Yonglin Lu,Xia Zhang,Haiping Wang,Junyi Han,Chunyan Dong

DOI: https://doi.org/10.2147/dddt.s112039

IF: 4.3188

2016-01-01

Drug Design Development and Therapy

Abstract:Folate-conjugated, curcumin-loaded human serum albumin nanoparticles (F-CM-HSANPs) were obtained by the chemical conjugation of folate to the surface of the curcumin (CM)-loaded human serum albumin nanoparticles (NPs). The NPs were characterized by various parameters, including size, polydispersity, zeta potential, morphology, encapsulation efficiency, and drug release profile. The mean particle size of F-CM-HSANPs was 165.6±15.7 nm (polydispersity index <0.28), and the average encapsulation efficiency percentage and drug loading percentage of the F-CM-HSANPs were 88.7%±4.8% and 7.9%±0.4%, respectively. Applied in vitro, the CM NPs, after conjugation with folate, maintained sustained release, and a faster release of CM was more visibly observed than the unconjugated NPs. F-CM-HSANPs can prolong the retention time of CM significantly in vivo. However, after intravenous injection of F-CM-HSANPs, the pharmacokinetic parameters of CM were not significantly different from those of CM-loaded human serum albumin NPs. The improved antitumor activity of F-CM-HSANPs may be attributable to the protection of drug from enzymatic deactivation followed by the selective localization at the desired site. These results suggest that the intravenous injection of F-CM-HSANPs is likely to have an advantage in the current clinical CM formulation, because it does not require the use of a solubilization agent and it is better able to target the tumor tissue.
Curcumin loaded gold nanoparticles-chitosan/sodium alginate nanocomposite for nanotheranostic applications

Balu Kolathupalayam Shanmugam,Nidhusha Rajendran,Karthik Arumugam,Suriyaprabha Rangaraj,Karthik Subramani,Surendhiran Srinivasan,Lenin Nayagam,Wilhelm Karl Aicher,Rajendran Venkatachalam

DOI: https://doi.org/10.1080/09205063.2022.2151819

Abstract:A solvent casting technique was used for the preparation of biomimetic nanocomposites scaffolds at three various concentrations of Curcumin loaded gold nanoparticles (Cur-AuNPs-1, 1.5, and 2 ml) as filler materials with chitosan-sodium alginate composite. The physico-chemical properties of prepared Cu-Au NPs and biomimetic nanocomposites were analyzed using various characterization techniques. In vitro biocompatibility of biomimetic nanocomposites are determined using simulated body fluid for biomineralization property, HAp formation and phosphate buffer saline (PBS) for swelling property, protein adsorption. Antibacterial activity of Cur-Au NPs and their nanocomposites carried out against Escherichia coli (E. coli) and Staphylococcus aureus. In vitro cytotoxicity of Cur-AuNPs is identified against UC-6 and MDA-MB 231 cell lines. The use of above studies and activity of Cur-AuNPs with contain biomimetic nanocomposites can adoptable for nanotheranostics.
Bovine Serum Albumin Nanoparticles for the Efficient Delivery of Berberine: Preparation, Characterization and In vitro biological studies

Raghu Solanki,Krunal Patel,Sunita Patel

DOI: https://doi.org/10.1016/j.colsurfa.2020.125501

2021-01-01

Abstract:Berberine (BBR) is a naturally occurring plant-derived isoquinoline alkaloid. It has been reported to exhibit multiple pharmacological properties including anticancer activity. However, its low water solubility and bioavailability restrict its clinical use for cancer treatment. Hence, to overcome these limitations and enhance its therapeutic efficacy, in the present study we have encapsulated BBR in Bovine Serum Albumin nanoparticles (BSA NPs) by desolvation method. The average particle size of synthesized nanoparticles were found to be 116 and 166 nm for BSA NPs and BBR-BSA NPs respectively. The FESEM images of nanoparticles implied that prepared nanoparticles are of spherical shape and size was validated. The drug entrapment efficiency of prepared nanoparticles was found to be 85.65 % with a drug loading capacity of 7.78 %. The FTIR spectra, XRD patterns and thermograms of DSC and TGA confirms the synthesis of BBR-BSA NPs and its entrapment in amorphous form. The stability studies of BBR-BSA NPs suggests that nanoparticles were quite stable in aqueous solution of pH 7.4 and degraded under acidic condition (pH 5). The in vitro cytotoxicity assay and Trypan blue assay proved that the prepared BBR-BSA NPs were selectively toxic towards breast cancer cells and kill the cells more efficiently as compared to pure BBR. The cellular uptake studies and AO/EtBr staining suggest that BBR-BSA NPs were therapeutically more effective and improve the anticancer activity of BBR by delivering it to target site, for potential therapeutic use. All the above information collectively suggests that BBR-BSA NPs may emerge as a novel paradigm for treatment of breast cancer.
Application of a novel pH-responsive gemini surfactant for delivery of curcumin molecules

Maral Rahimzadeh,Majid Sadeghizadeh,Farhood Najafi,Seyed Shahriar Arab,Pouneh Sadat Pourhosseini

DOI: https://doi.org/10.1088/2053-1591/ab770f

IF: 2.025

2020-06-01

Materials Research Express

Abstract:Abstract During the last few decades, extensive studies have been conducted to elucidate the anti-cancer effects of curcumin. Despite promising results indicating curcumin could impede cancer cells ability thrive and proliferation, clinical applications of it have been limited. This limitation is mainly due to low solubility, poor bioavailability, rapid metabolism, and deficient absorption. To improve the physiochemical properties of curcumin, we have synthesized a novel biodegradable gemini surfactant in which curcumin molecules were entrapped. Gemini surfactant-curcumin nanocapsules were prepared using nanoprecipitation method and characterized by several techniques including, DLS, TEM, AFM, FTIR, DSC and XRD. The in vitro MTT assay, cellular uptake, and apoptosis assay were performed using MDA-MB-231 cell line. The gemini surfactant molecules were able to form vesicles in aqueous solution with a narrow size distribution (PDI ≅ 0.3). An encapsulation efficiency of 87.45 ± 2.3% and the drug loading content of 4.98 ± 0.12% were acquired. Curcumin molecules were dispersed in the hydrophobic shell of the vesicles, and sustained release profile was observed. Due to the increased cellular uptake and sustained release profile, the gemini surfactant-curcumin nanocapsules exhibited higher cytotoxicity and enhanced apoptosis in MDA-MB-231 cells compared to free curcumin. The results indicate that gemini surfactant-curcumin complex shows considerable promise as an anti-breast cancer drug.

materials science, multidisciplinary
Investigation of Folate-Functionalized Magnetic-Gold Nanoparticles Based Targeted Drug Delivery for Liver: In Vitro, In Vivo and Docking Studies

Ali Hussein F Alnasraui,I Hubert Joe,Sharafaldin Al-Musawi

DOI: https://doi.org/10.1021/acsbiomaterials.4c01039

2024-09-02

Abstract:Magnetic nanoparticles used for targeted drug administration present a promising approach in cancer treatment owing to its notable advantages, such as targeted and enhanced encapsulation ability and improved bio protection compared with conventional drug delivery methods. Au shell-iron core nanoparticles (Fe3O4@Au) were manufactured by a chemical process, coated with dextran to encapsulate curcumin, and functionalized for precision drug delivery using folic acid to combat liver cancer. Dynamic light scattering, scanning electron microscopy, transmission electron microscopy, vibrational spectroscopy, and magnetometry were applied to assess the synthesis of the Fe3O4@Au-DEX-CU-FA compound. The mean size, zeta potential, and polydispersity of Fe3O4@Au-DEX-CU-FA were 63.3 ± 2.33 nm, -68.3 ± 1.78 mV, and 0.041 ± 0.008, respectively. Molecular docking models were created to examine the relationship between Fe3O4@Au-CU and BCL-XL, BAK, and to identify potential binding sites. The loading efficiency and release profile tests examined the medication delivery system's ability. MTT assay was subsequently utilized to determine the optimal dosage and therapeutic efficacy of Fe3O4@Au-DEX-CU-FA on cancer SNU-449 and healthy THLE-2 cell lines. Flow cytometry demonstrated that Fe3O4@Au-DEX-CU-FA effectively induced cancer cell death. Fe3O4@Au-DEX-FA showed a regulated release profile of free curcumin at 37 °C and pH values of 7.4 and 5.4. Real-time PCR revealed increased BAK expression and decreased BCL-XL expression. Nude tumor-bearing mice were used for in vivo experiments. Fe3O4@Au-DEX-CU-FA treatment dramatically reduced the swelling size compared with free CU and control treatments. It also resulted in a longer lifespan, expanded splenocyte proliferation, increased IFN-γ levels, and decreased IL-4 levels. The regular cells showed no cytotoxic effect compared with the cancer type, confirming that Fe3O4@Au-DEX-CU-FA maintained its potent anticancer actions. The data suggests that Fe3O4@Au-DEX-CU-FA possesses a promising potential as a therapeutic agent for combating tumors.
Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line

Elham Afzali,Touba Eslaminejad,Seyede Elmira Yazdi Rouholamini,Mariam Shahrokhi-Farjah,Mehdi Ansari

DOI: https://doi.org/10.2147/IJN.S251056

2021-01-25

Abstract:Purpose: Breast cancer is one of the most lethal types of cancer in women. Curcumin showed therapeutic potential against breast cancer, but applying that by itself does not lead to the associated health benefits due to its poor bioavailability, which appears to be primarily due to poor absorption, rapid metabolism, and rapid elimination. Moreover, poor water solubility of curcumin causes accumulation of a high concentration of curcumin and so decrease its permeability to the cell. Many strategies are employed to reduce curcumin metabolism such as adjuvants and designing novel delivery systems. Therefore, in this study sodium alginate and chitosan were used to synthesize the hydrogels that are known as biocompatible, hydrophilic and low toxic drug delivery systems. Also, folic acid was used to link to chitosan in order to actively targetfolate receptors on the cells. Methods: Chitosan-β-cyclodextrin-TPP-Folic acid/alginate nanoparticles were synthesized and then curcumin was loaded on them. Interaction between the constituents of the particles was characterized by FTIR spectroscopy. Morphological structures of samples were studied by FE-SEM. Release profile of curcumin was determined by dialysis membrane. The cytotoxic test was done on the Kerman male breast cancer (KMBC-10) cell line by using MTT assay. The viability of cells was detected by fluorescent staining. Gene expression was investigated by real-time PCR. Results: The encapsulation of curcumin into nano-particles showed an almost spherical shape and an average particle size of 155 nm. In vitro cytotoxicity investigation was indicated as dose-respond reaction against cancer breast cells after 24 h incubation. On the other hand, in vitro cell uptake study revealed active targeting of CUR-NPs into spheroids. Besides, CXCR 4 expression was detected about 30-fold less than curcumin alone. The CUR-NPs inhibited proliferation and increased apoptosis in spheroid human breast cancer cells. Conclusion: Our results showed the potential of NPs as an effective candidate for curcumin delivery to the target tumor spheroids that confirmed the creatable role of folate receptors.
Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin

Farrukh Aqil,Radha Munagala,Jeyaprakash Jeyabalan,Ashish Kumar Agrawal,Ramesh Gupta

DOI: https://doi.org/10.1208/s12248-017-0154-9

2017-10-18

The AAPS Journal

Abstract:Exosomes are extracellular microvesicles with a particle size of 30–100 nm and carry a cargo of proteins, lipids, RNA, and DNA. Their properties of shuttling in-and-out of the cells suggest that these particles can be exploited as a nano drug carrier. In this manuscript, we show that curcumin can be delivered effectively using milk-derived exosomes. Curcumin when mixed with exosomes in the presence of 10% ethanol:acetonitrile (1:1) provided a drug load of 18–24%, and the formulation stored at − 80°C was stable for 6 months as determined by particle size analysis, drug load, and antiproliferative activity. The uptake of exosomes by cancer cells involved caveolae/clathrin-mediated endocytosis. Oral administration of exosomal curcumin (ExoCUR) in Sprague-Dawley rats demonstrated 3–5 times higher levels in various organs versus free agent. ExoCUR showed enhanced antiproliferative activity against multiple cancer cell lines including, breast, lung, and cervical cancer compared with the free curcumin. ExoCUR showed significantly higher anti-inflammatory activity measured as NF-κB activation in human lung and breast cancer cells. To determine in vivo antitumor activity, nude mice bearing the cervical CaSki tumor xenograft were treated with ExoCUR by oral gavage, curcumin diet, exosomes alone, and PBS as controls. While curcumin via dietary route failed to elicit any effect, exosomes had a modest (25–30%) tumor growth inhibition. However, ExoCUR showed significant inhibition (61%; p < 0.01) of the cervical tumor xenograft. No gross or systemic toxicity was observed in the rats administered with the exosomes or ExoCUR. These results suggest that exosomes can be developed as potential nano carriers for delivering curcumin which otherwise has encountered significant tissue bioavailability issues in the past.
Albumin-based nanoparticles combined with photodynamic therapy enhance the antitumor activity of curcumin derivative C086

Chen He,Lei Zhang,Wenzhen Liu,Yunmei Huang,Ping Hu,Tao Dai,Jianhua Xu,Zhuo Chen

DOI: https://doi.org/10.1016/j.dyepig.2021.109258

IF: 5.122

2021-05-01

Dyes and Pigments

Abstract:C086, a derivative of curcumin, was previously identified as a novel heat shock protein 90 (Hsp90) inhibitor and was found to exhibit stronger anti-tumor activity than curcumin. However, the inferior water solubility of C086 limits both its bioavailability and therapeutic efficacy. In this study, we aimed to improve the solubility and consequently the bioavailability of C086 via the albumin-based nanoparticles (NPs). The C086-loaded human serum albumin () NPs were fabricated by a simple self-assembly method. The resulting NPs with an average diameter size of 36 nm, combined with photodynamic therapy, showed significant cytotoxic activity against all tumor cell lines investigated along with longer duration of effect than pure C086. More investigation was carried on the anti-tumor mechanism of NPs, showing that its anti-tumor effect of photodynamic therapy (PDT) on human cervical carcinoma HeLa cells was associated with apoptosis and cell cycle arrest at the S and G2/M phase upon 10-min blue light illumination (450 nm, 5 mW/cm2). Furthermore, the in vivo antitumor activity of NPs was evaluated in 4T1 tumor-bearing mouse model using intense blue light (80 mW/cm2), confirming the enhanced antitumor activity of NPs through photodynamic therapy. Taken together, our work provides an efficient albumin-based nanoparticle drug delivery platform to improve the bioavailability and therapeutic efficacy of hydrophobic photosensitizers against tumor growth.

engineering, chemical,chemistry, applied,materials science, textiles
Studying the Characteristics of Curcumin-Loaded Liposomal Nanoparticles

Iman Afyouni,Parizad Ghanbarikondori,Niki Sadeghi Pour,Paria Mir Hashemian,Fereshtehsadat Jalali,Armin Sedighi,Mohammadreza Allahyartorkaman

DOI: https://doi.org/10.31557/apjcb.2024.9.2.183-189

2024-05-29

Asian Pacific Journal of Cancer Biology

Abstract:Overview: In this study, the physical and chemical properties of curcumin are extensively examined when it is incorporated into liposome nanoparticles, to enhance its therapeutic potency and bioavailability. Curcumin, a plant-derived polyphenol, has garnered attention for its anti-inflammatory, antioxidant, and anti-cancer activities. However, its clinical utility is hindered by several limitations, including poor water solubility, inadequate absorption, and rapid metabolism. By leveraging the potential of liposome nanoparticles to improve drug delivery and efficacy, this research aims to overcome these obstacles and unlock the full therapeutic potential of curcumin. Methods: Curcumin-loaded liposome nanoparticles (CLLNs) were fabricated employing a thin-film hydration method, after sonication. The physicochemical attributes of CLLNs were subsequently characterized, encompassing particle size and zeta potential assessment utilizing dynamic light scattering (DLS), encapsulation efficiency (EE%) and drug loading efficiency (DLE%) determination through high-performance liquid chromatography (HPLC), investigation of in vitro drug release patterns in simulated biological fluids. Results: The CLLNs optimized in this study had a mean particle diameter of less than 250 nm and a negative surface charge, implying good stability and potential for cellular uptake. The encapsulation efficiency and drug loading efficiency were both found to be high, indicating that curcumin was effectively loaded into the liposomes. In vitro release testing showed a sustained release pattern of curcumin from the CLLNs. Conclusion: The research offered important observations about the advantageous physicochemical features of curcumin-loaded liposome nanoparticles, highlighting their potential as a cutting-edge delivery system for curcumin. The study demonstrated that CLLNs have high encapsulation and drug loading efficiencies, as well as controlled release and improved stability, which suggests their ability to enhance the therapeutic benefits of curcumin. These findings set the stage for future in vivo and clinical trials to fully investigate the potential of CLLNs in medical applications.
Amphiphilic Curcumin Conjugate-Forming Nanoparticles As Anticancer Prodrug and Drug Carriers: in Vitro and in Vivo Effects

Huadong Tang,Caitlin J. Murphy,Bo Zhang,Youqing Shen,Meihua Sui,Edward Alva Van Kirk,Xiaowen Feng,William J. Murdoch

DOI: https://doi.org/10.2217/nnm.10.67

2010-01-01

Nanomedicine

Abstract:Curcumin has been shown to have high cytotoxicity towards various cancer cell lines, but its water insolubility and instability make its bioavailability exceedingly low and, thus, it is generally inactive in in vivo anticancer tests. Here, we report an intracellular-labile amphiphilic surfactant-like curcumin prodrug curcumin conjugated with two short oligo(ethylene glycol) (Curc-OEG) chains via beta-thioester bonds that are labile in the presence of intracellular glutathione and esterase. Curc-OEG formed stable nanoparticles in aqueous conditions and served two roles - as an anticancer prodrug and a drug carrier. As an anticancer prodrug, the formed nanoparticles had a high and fixed curcumin-loading content of 25.3 wt%, and released active curcumin in the intracellular environment. Curc-OEG had high inhibition ability to several cancer cell lines due to apoptosis. Intravenously injected Curc-OEG significantly reduced the tumor weights and tumor numbers in the athymic mice xenografted with intraperitoneal SKOV-3 tumors and subcutaneous (mammary fat pad) MDA-MB-468 tumors. Preliminary systemic toxicity studies found that Curc-OEG did not cause acute and subchronic toxicities to mouse visceral organs at high doses. As drug carriers, Curc-OEG nanoparticles could carry other anticancer drugs, such as doxorubicin and camptothecin, and ship them into drug-resistant cells, greatly enhancing the cytotoxicity of the loaded drug. Thus, Curc-OEG is a promising prototype that merits further study for cancer therapy.
Novel chitosan/γ-alumina/carbon quantum dot hydrogel nanocarrier for targeted drug delivery

Mohammad Hossein Karami,Mehrab Pourmadadi,Majid Abdouss,Mohammad Reza Kalaee,Omid Moradi,Abbas Rahdar,Ana M Díez-Pascual

DOI: https://doi.org/10.1016/j.ijbiomac.2023.126280

2023-11-01

Abstract:Curcumin (CUR) is among the most natural and effective antitumor drugs for cancer treatment. These drugs have low solubility and short half-lives that reduce their effectiveness in drug release systems. Herein, a hydrogel nanocarrier containing chitosan (CS), alumina (γ-Al2O3), and carbon quantum dots (CQDs) was prepared by the water-in-oil-in-water (W/O/W) double nanoemulsion method. DLS revealed a nanocarrier size of 227 nm, with a zeta potential of -37.8 mV, which corroborates its stability. FE-SEM showed its quasi-spherical shape, FT-IR and XRD confirmed the presence of all the components in the nanocomposite and gave information about the intermolecular interactions between them and the crystalline nature of the nanocarrier, respectively. The drug loading (48 %) and entrapment efficiency (86 %) were higher than those reported previously for other CUR nanocarriers. The drug release profile revealed a controlled and stable release, and a pH-sensitive behavior, with faster CUR release in an acid environment. The breast cancer cell line was examined by cytotoxicity and cell apoptosis analyses. The results showed that the slow release over time and the programmed cell death were due to interactions between CUR and the nanocarrier. Considering the results obtained herein, CS/γAl2O3/CQDs/CUR can be considered as a promising new nanosystem for tumor treatment.

Bovine serum albumin/gold nanoparticles as a drug delivery system for Curcumin: experimental and computational studies

Preparation and Characterization of Bovine Serum Albumin Nanoparticles of Curcumin using a Chemometric Approach

Bovine Serum Albumin-Based Nanoparticles: Preparation, Characterization, and Antioxidant Activity Enhancement of Three Main Curcuminoids from Curcuma longa

Preparation and Characterization of PEG-albumin-curcumin Nanoparticles Intended to Treat Breast Cancer

Fabrication of Ovalbumin/κ-Carrageenan Complex Nanoparticles As a Novel Carrier for Curcumin Delivery

Nanoparticulation of bovine serum albumin and poly-d-lysine through complex coacervation and encapsulation of curcumin

Interactions of Turmeric- and Curcumin-Functionalized Gold Nanoparticles with Human Serum Albumin: Exploration of Protein Corona Formation, Binding, Thermodynamics, and Antifibrillation Studies

In Vitro Characterization and in Vivo Evaluation of Nanostructured Lipid Curcumin Carriers for Intragastric Administration

Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations

Berberine-Loaded Bovine Serum Albumin Nanoparticles: Fabrication, Characterization, and Drug Release Evaluation

Novel Curcumin-Loaded Human Serum Albumin Nanoparticles Surface Functionalized with Folate: Characterization and in Vitro/vivo Evaluation

Curcumin loaded gold nanoparticles-chitosan/sodium alginate nanocomposite for nanotheranostic applications

Bovine Serum Albumin Nanoparticles for the Efficient Delivery of Berberine: Preparation, Characterization and In vitro biological studies

Application of a novel pH-responsive gemini surfactant for delivery of curcumin molecules

Investigation of Folate-Functionalized Magnetic-Gold Nanoparticles Based Targeted Drug Delivery for Liver: In Vitro, In Vivo and Docking Studies

Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line

Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin

Albumin-based nanoparticles combined with photodynamic therapy enhance the antitumor activity of curcumin derivative C086

Studying the Characteristics of Curcumin-Loaded Liposomal Nanoparticles

Amphiphilic Curcumin Conjugate-Forming Nanoparticles As Anticancer Prodrug and Drug Carriers: in Vitro and in Vivo Effects

Novel chitosan/γ-alumina/carbon quantum dot hydrogel nanocarrier for targeted drug delivery